Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Advanced Blood-Brain Barrier Permeability Imaging for Early Alzheimer's Disease

NCT03389698 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03389698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03389698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Advanced Blood-Brain Barrier Permeability Imaging for Early Alzheimer's Disease
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
December 18, 2018
Completion date
July 11, 2023
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease